Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Losman, B; Bolmstedt, A; Schonning, K; Bjorndal, A; Westin, C; Fenyo, EM; Olofsson, S
   Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type I glycoprotein 120 by N-linked oligosaccharides in the V1 region
   AIDS RESEARCH AND HUMAN RETROVIRUSES
   
   B. Losman et al., "Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type I glycoprotein 120 by N-linked oligosaccharides in the V1 region", AIDS RES H, 17(11), 2001, pp. 1067-1076
2. Bolmstedt, A; Hinkula, J; Rowcliffe, E; Biller, M; Wahren, B; Olofsson, S
   Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals - Effects of elimination of the V3N306 glycan
   VACCINE
   
   A. Bolmstedt et al., "Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals - Effects of elimination of the V3N306 glycan", VACCINE, 20(3-4), 2001, pp. 397-405
3. Biller, M; Mardberg, K; Hassan, H; Clausen, H; Bolmstedt, A; Bergstrom, T; Olofsson, S
   Early steps in O-linked glycosylation and clustered O-linked glycans of herpes simplex virus type 1 glycoprotein C: effects on glycoprotein properties
   GLYCOBIOLOGY
   
   M. Biller et al., "Early steps in O-linked glycosylation and clustered O-linked glycans of herpes simplex virus type 1 glycoprotein C: effects on glycoprotein properties", GLYCOBIOLOG, 10(12), 2000, pp. 1259-1269
4. Olofsson, S; Bolmstedt, A; Biller, M; Mardberg, K; Leckner, J; Malmstrom, BG; Trybala, E; Bergstrom, T
   The role of a single N-linked glycosylation site for a functional epitope of herpes simplex virus type 1 envelope glycoprotein gC
   GLYCOBIOLOGY
   
   S. Olofsson et al., "The role of a single N-linked glycosylation site for a functional epitope of herpes simplex virus type 1 envelope glycoprotein gC", GLYCOBIOLOG, 9(1), 1999, pp. 73-81
5. Losman, B; Biller, M; Olofsson, S; Schonning, K; Lund, OS; Svennerholm, B; Hansen, JES; Bolmstedt, A
   The N-linked glycan of the V3 region of HIV-1 gp120 and CXCR4-dependent multiplication of a human immunodeficiency virus type 1 lymphocyte-tropic variant
   FEBS LETTERS
   
   B. Losman et al., "The N-linked glycan of the V3 region of HIV-1 gp120 and CXCR4-dependent multiplication of a human immunodeficiency virus type 1 lymphocyte-tropic variant", FEBS LETTER, 454(1-2), 1999, pp. 47-52
6. LUND OS; LOSMAN B; SCHONNING K; BOLMSTEDT A; OLOFSSON S; HANSEN JES
   INHIBITION OF HIV TYPE-1 INFECTIVITY BY COEXPRESSION OF A WILD-TYPE AND A DEFECTIVE GLYCOPROTEIN-120
   AIDS research and human retroviruses
   
   O.S. Lund et al., "INHIBITION OF HIV TYPE-1 INFECTIVITY BY COEXPRESSION OF A WILD-TYPE AND A DEFECTIVE GLYCOPROTEIN-120", AIDS research and human retroviruses, 14(16), 1998, pp. 1445-1450
7. SCHONNING K; BOLMSTEDT A; NOVOTNY J; LUND OS; OLOFSSON S; HANSEN JES
   INDUCTION OF ANTIBODIES AGAINST EPITOPES INACCESSIBLE ON THE HIV TYPE-1 ENVELOPE OLIGOMER BY IMMUNIZATION WITH RECOMBINANT MONOMERIC GLYCOPROTEIN-120
   AIDS research and human retroviruses
   
   K. Schonning et al., "INDUCTION OF ANTIBODIES AGAINST EPITOPES INACCESSIBLE ON THE HIV TYPE-1 ENVELOPE OLIGOMER BY IMMUNIZATION WITH RECOMBINANT MONOMERIC GLYCOPROTEIN-120", AIDS research and human retroviruses, 14(16), 1998, pp. 1451-1456
8. Biller, M; Bolmstedt, A; Hemming, A; Olofsson, S
   Simplified procedure for fractionation and structural characterisation of complex mixtures of N-linked glycans, released from HIV-1 gp120 and other highly glycosylated viral proteins.
   JOURNAL OF VIROLOGICAL METHODS
   
   M. Biller et al., "Simplified procedure for fractionation and structural characterisation of complex mixtures of N-linked glycans, released from HIV-1 gp120 and other highly glycosylated viral proteins.", J VIROL MET, 76(1-2), 1998, pp. 87-100
9. BOLMSTEDT A; BILLER M; HANSEN JES; MOORE JP; OLOFSSON S
   DEMONSTRATION OF PERIPHERAL FUCOSE UNITS IN N-LINKED GLYCANS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP-120 - EFFECTS ON GLYCOPROTEIN CONFORMATION
   Archives of virology
   
   A. Bolmstedt et al., "DEMONSTRATION OF PERIPHERAL FUCOSE UNITS IN N-LINKED GLYCANS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP-120 - EFFECTS ON GLYCOPROTEIN CONFORMATION", Archives of virology, 142(12), 1997, pp. 2465-2481
10. BOLMSTEDT A; SJOLANDER S; HANSEN JES; AKERBLOM L; HEMMING A; HU SL; MOREIN B; OLOFSSON S
    INFLUENCE OF N-LINKED GLYCANS IN V4-V5 REGION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN GP160 ON INDUCTION OF A VIRUS-NEUTRALIZING HUMORAL RESPONSE
    Journal of acquired immune deficiency syndromes and human retrovirology
    
    A. Bolmstedt et al., "INFLUENCE OF N-LINKED GLYCANS IN V4-V5 REGION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN GP160 ON INDUCTION OF A VIRUS-NEUTRALIZING HUMORAL RESPONSE", Journal of acquired immune deficiency syndromes and human retrovirology, 12(3), 1996, pp. 213-220
11. HEMMING A; GRAM GJ; BOLMSTEDT A; LOSMAN B; HANSEN JES; RICKSTEN A; OLOFSSON S
    CONSERVED N-LINKED OLIGOSACCHARIDES OF THE C-TERMINAL PORTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 AND VIRAL SUSCEPTIBILITY TO NEUTRALIZING ANTIBODIES
    Archives of virology
    
    A. Hemming et al., "CONSERVED N-LINKED OLIGOSACCHARIDES OF THE C-TERMINAL PORTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 AND VIRAL SUSCEPTIBILITY TO NEUTRALIZING ANTIBODIES", Archives of virology, 141(11), 1996, pp. 2139-2151
12. SJOLANDER S; BOLMSTEDT A; AKERBLOM L; HORAL P; OLOFSSON S; MOREIN B; SJOLANDER A
    N-LINKED GLYCANS IN THE CD4-BINDING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN GP160 ARE ESSENTIAL FOR THE IN-VIVOPRIMING OF T-CELLS RECOGNIZING AN EPITOPE LOCATED IN THEIR VICINITY
    Virology
    
    S. Sjolander et al., "N-LINKED GLYCANS IN THE CD4-BINDING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN GP160 ARE ESSENTIAL FOR THE IN-VIVOPRIMING OF T-CELLS RECOGNIZING AN EPITOPE LOCATED IN THEIR VICINITY", Virology, 215(2), 1996, pp. 124-133
13. VOOG E; BOLMSTEDT A; OLOFSSON S; RYD W; LOWHAGEN GB
    HUMAN PAPILLOMA-VIRUS INFECTION AMONG WOMEN ATTENDING AN STD CLINIC CORRELATED TO REASON FOR ATTENDING, PRESENCE OF CLINICAL SIGNS, CONCOMITANT INFECTIONS AND ABNORMAL-CYTOLOGY
    Acta dermato-venereologica
    
    E. Voog et al., "HUMAN PAPILLOMA-VIRUS INFECTION AMONG WOMEN ATTENDING AN STD CLINIC CORRELATED TO REASON FOR ATTENDING, PRESENCE OF CLINICAL SIGNS, CONCOMITANT INFECTIONS AND ABNORMAL-CYTOLOGY", Acta dermato-venereologica, 75(1), 1995, pp. 75-78
14. GRAM GJ; HEMMING A; BOLMSTEDT A; JANSSON B; OLOFSSON S; AKERBLOM L; NIELSEN JO; HANSEN JES
    IDENTIFICATION OF AN N-LINKED GLYCAN IN THE V1-LOOP OF HIV-1 GP120 INFLUENCING NEUTRALIZATION BY ANTI-V3 ANTIBODIES AND SOLUBLE CD4
    Archives of virology
    
    G.J. Gram et al., "IDENTIFICATION OF AN N-LINKED GLYCAN IN THE V1-LOOP OF HIV-1 GP120 INFLUENCING NEUTRALIZATION BY ANTI-V3 ANTIBODIES AND SOLUBLE CD4", Archives of virology, 139(3-4), 1994, pp. 253-261
15. HEMMING A; BOLMSTEDT A; JANSSON B; HANSEN JES; TRAVIS B; HU SL; OLOFSSON S
    IDENTIFICATION OF 3 N-LINKED GLYCANS IN THE V4-V5 REGION OF HIV-1 GP-120, DISPENSABLE FOR CD4-BINDING AND FUSION ACTIVITY OF GP-120
    Archives of virology
    
    A. Hemming et al., "IDENTIFICATION OF 3 N-LINKED GLYCANS IN THE V4-V5 REGION OF HIV-1 GP-120, DISPENSABLE FOR CD4-BINDING AND FUSION ACTIVITY OF GP-120", Archives of virology, 134(3-4), 1994, pp. 335-344
16. MCKEATING JA; SHOTTON C; CORDELL J; GRAHAM S; BALFE P; SULLIVAN N; CHARLES M; PAGE M; BOLMSTEDT A; OLOFSSON S; KAYMAN SC; WU Z; PINTER A; DEAN C; SODROSKI J; WEISS RA
    CHARACTERIZATION OF NEUTRALIZING MONOCLONAL-ANTIBODIES TO LINEAR AND CONFORMATION-DEPENDENT EPITOPES WITHIN THE 1ST AND 2ND VARIABLE DOMAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120
    Journal of virology
    
    J.A. Mckeating et al., "CHARACTERIZATION OF NEUTRALIZING MONOCLONAL-ANTIBODIES TO LINEAR AND CONFORMATION-DEPENDENT EPITOPES WITHIN THE 1ST AND 2ND VARIABLE DOMAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120", Journal of virology, 67(8), 1993, pp. 4932-4944